Sort by
Keyphrases
United States
100%
Dialysis Patients
100%
Peritoneal Dialysis Patients
100%
Undertreatment
100%
Kidney Dialysis
100%
Hemodialysis
75%
Atherosclerotic Cardiovascular Disease (ASCVD)
50%
Dialysis
25%
Diabetes
25%
High Risk
25%
Patient Demographics
25%
Clinical High Risk
25%
Mortality Rate
25%
Randomized Clinical Trial
25%
Treatment Patterns
25%
Low Mortality
25%
Peritoneal Dialysis
25%
Lipid-lowering Agents
25%
Low-density Lipoprotein Cholesterol (LDL-C)
25%
Serum Cholesterol
25%
Cardiovascular Risk Reduction
25%
Cardiovascular Disease Events
25%
Adult Treatment
25%
National Guidelines
25%
Dialysis Facility
25%
Cholesterol Treatment
25%
National Cholesterol Education Program
25%
Incident Hemodialysis
25%
Medicine and Dentistry
Hyperlipidemia
100%
Renal Replacement Therapy
100%
Peritoneal Dialysis
83%
Hemodialysis
66%
Prevalence
33%
Cardiovascular Disease
33%
Arteriosclerotic Heart Disease
33%
Diabetes
16%
Patient Population
16%
End Stage Renal Disease
16%
Hypolipidemic Agent
16%
Risk Reduction
16%
Low Density Lipoprotein Cholesterol
16%
Randomized Clinical Trials
16%
Lower Mortality Rate
16%
Nursing and Health Professions
Hyperlipidemia
100%
Renal Replacement Therapy
100%
Peritoneal Dialysis
83%
Hemodialysis
66%
Prevalence
33%
Practice Guideline
33%
Cardiovascular Disease
33%
Coronary Artery Atherosclerosis
33%
Patient Population
16%
Mortality Rate
16%
End Stage Renal Disease
16%
Cholesterol Blood Level
16%
Antilipemic Agent
16%
Low Density Lipoprotein Cholesterol
16%
Biochemistry, Genetics and Molecular Biology
Hyperlipidemia
100%
Peritoneal Dialysis
83%
Hemodialysis
66%
Prevalence
33%
Lipid
16%
Mortality Rate
16%
Cholesterol Blood Level
16%
Risk Reduction
16%
Randomized Clinical Trial
16%
Low-Density Lipoprotein
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperlipidemia
100%
Hemodialysis
66%
Prevalence
33%
Coronary Artery Atherosclerosis
33%
Cardiovascular Disease
33%
Mortality Rate
16%
End Stage Renal Disease
16%
Randomized Clinical Trial
16%
Low Density Lipoprotein Cholesterol
16%
Antilipemic Agent
16%